These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24631370)

  • 1. SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor.
    Sakamoto LH; Andrade RV; Felipe MS; Motoyama AB; Pittella Silva F
    Leuk Res; 2014 Apr; 38(4):496-502. PubMed ID: 24631370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of SET and MYND domain-containing protein 2 (
    Zhang P; Ruan J; Weng W; Tang Y
    Leuk Lymphoma; 2020 Feb; 61(2):437-444. PubMed ID: 31612757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of two CpG sites upstream of CASP8AP2 promoter influences gene expression and treatment outcome in childhood acute lymphoblastic leukemia.
    Li ZG; Jiao Y; Li WJ; Deng GR; Cui L; Gao C; Zhao XX; Wu MY; Jia HT
    Leuk Res; 2013 Oct; 37(10):1287-93. PubMed ID: 23953914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOXA9 and MEIS1 gene overexpression in the diagnosis of childhood acute leukemias: Significant correlation with relapse and overall survival.
    Adamaki M; Lambrou GI; Athanasiadou A; Vlahopoulos S; Papavassiliou AG; Moschovi M
    Leuk Res; 2015 Aug; 39(8):874-82. PubMed ID: 26059450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMYD2 Expression: Its Relationship to Cytogenetic and Prognosis in a Newly Diagnosed Childhood B-Acute Lymphoblastic Leukemia.
    Gawdat RM; Khalil SA; Hassan NM; Nabil R; Alazhary NM
    Clin Lab; 2023 Mar; 69(3):. PubMed ID: 36912291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia.
    Jiao Y; Cui L; Gao C; Li W; Zhao X; Liu S; Wu M; Deng G; Li Z
    Leuk Res; 2012 Jan; 36(1):67-71. PubMed ID: 21696825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
    Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
    Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognosis markers in pediatric high-risk acute lymphoblastic leukemia.
    Al-Lamki Z; Wali YA; Wasifuddin SM; Zachariah M; Al-Mjeni R; Li C; Muralitharan S; Al-Kharusi K; Gunaratne P; Peterson L; Gibbs R; Gingras MC; Margolin JF
    Pediatr Hematol Oncol; 2005; 22(7):629-43. PubMed ID: 16166056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Ruano D; Diaz MA; Tutor O; Garcia-Sanchez F; Martinez P; Madero L
    Haematologica; 2000 Aug; 85(8):877-8. PubMed ID: 10942942
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia.
    Holm C; Ora I; Brunhoff C; Anagnostaki L; Landberg G; Persson JL
    Leuk Res; 2006 Mar; 30(3):254-61. PubMed ID: 16182364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia.
    Moreno DA; Scrideli CA; Cortez MA; de Paula Queiroz R; Valera ET; da Silva Silveira V; Yunes JA; Brandalise SR; Tone LG
    Br J Haematol; 2010 Sep; 150(6):665-73. PubMed ID: 20636436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2.
    Abu-Farha M; Lanouette S; Elisma F; Tremblay V; Butson J; Figeys D; Couture JF
    J Mol Cell Biol; 2011 Oct; 3(5):301-8. PubMed ID: 22028380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WT1 protein expression in childhood acute leukemia.
    Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
    Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
    Wiersma SR; Ortega J; Sobel E; Weinberg KI
    N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immunophenotypic signatures by clustering analysis in pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Buldini B; Zangrando A; Michielotto B; Veltroni M; Giarin E; Tosato F; Cazzaniga G; Biondi A; Basso G
    Am J Hematol; 2010 Feb; 85(2):138-41. PubMed ID: 20095033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.